联邦留学辅导
鸣挚海外家政服务
代购代带网
人口普查
买书

英国伦敦华人网 - 英国伦敦第一中文门户网站

 找回密码
 注册

扫一扫,访问微社区

Certain COVID-19 experiments in Beijing prohibited

2023-2-5 02:00| 发布者: leedell| 查看: 82| 评论: 0|原作者: Mo Honge|来自: chinadaily.com.cn

摘要: A researcher works at a lab in a health industrial park in Yongchuan district of Chongqing, on Dec 16, 2022. (Photo/Xinhua)Conducting experiments related to COVID-19 in Beijing that go beyond an appro ...

A researcher works at a lab in a health industrial park in Yongchuan district of Chongqing, on Dec 16, 2022. (Photo/Xinhua)

Conducting experiments related to COVID-19 in Beijing that go beyond an approved range is prohibited, and laboratories are required to set up special repositories to store virus strains or samples, according to a notice released by the city's Health Commission on Wednesday.

Experimental activities including virus cultivation, animal infection experiments and nucleic acid testing can only be carried out with the approval of the National Health Commission or the city's Health Commission, in strict compliance with regulations governing COVID-19 lab biosafety management, the commission said.

Laboratories engaged in experimental activities involving COVID-19 should fulfill their main responsibilities, promote a detailed risk assessment and strengthen personnel protection. Special repositories should be set up to store novel coronavirus strains or samples, with double locks and monitoring equipment.

At the end of approved experiments, the coronavirus strains or samples should be disposed of under the regulations, or sent to storage.

Transportation of a novel coronavirus strain, along with uncultivated samples of infectious biological materials, may only be carried out after approval.

The commission also urged regional health departments to release clear information on related units and include them within the scope of key controls to strengthen supervision and inspection and effectively prevent biosecurity risks.

最新评论

广告合作(Contact Us)|关于我们|小黑屋|手机版|Archiver|伦敦华人网

GMT, 2024-11-23 23:50

Powered by Discuz! X3.4

© 2001-2013 Comsenz Inc.

返回顶部